Search results
Lynn Hlatky
GBH News· 13 hours agoThe mission of the Center of Cancer Systems Biology is based on the appreciation that carcinogenesis evolves at multiple levels ranging from molecular...
AI enabled body composition analysis predicts outcomes for patients with lung cancer treated with...
Medical Xpress· 3 days agoChaunzwa and senior author Hugo Aerts, Ph.D., director of the AIM Program, and associate professor...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoAN0025 is a selective EP4 inhibitor that demonstrates antitumor activity by modulating the function of macrophages and immunosuppressive...
Boston radiopharmaceuticals startup inks deal worth up to $1.16B with Lilly - Boston Business...
The Business Journals· 5 days agoA Boston radiopharmaceuticals startup that is already backed by three Big Pharma companies now has a...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
NBC San Diego· 3 days agoTargeted radiopharmaceuticals has caught the eye of big pharma. The therapy delivers radiation...
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 5 days agoRadiopharmaceuticals have become an attractive alternative to radiation therapy for treating certain...
Cedars-Sinai Experts Present Cancer News at ASCO A | Newswise
Newswise· 2 days agoCedars-Sinai Cancer physician-scientists and thought leaders will discuss scientific advances, new therapies, and the future of cancer care at the American
Study identifies differences in prostate cancer genomics among a racially and ethnically diverse...
Medical Xpress· 2 days agoDr. Luca Valle will present the findings at the annual American Society of Clinical Oncology meeting...
Penn Medicine at the 2024 ASCO Annual Meeting | Newswise
Newswise· 3 days agoExperts from Penn Medicine are available to comment on a wide range of cancer research and care topics before...
Targeting glutamine metabolism improves sarcoma response to radiation therapy in vivo -...
Nature· 6 days agoUsing primary mouse model of soft-tissue sarcoma (STS), authors show that sarcoma switches to glutamine metabolism post radiation therapy, and inhibition of glutaminolysis ...